Pre-order Enquiry
Request Free Sample
Global Spinal Muscular Atrophy (SMA) Treatment Market Size, Status and Forecast 2021-2027
SKU ID : QYR-17217998 | Publishing Date : 19-Jan-2021 | No. of pages : 98
Request Sample
Request Customization
Check DiscountsDetailed TOC of Global Spinal Muscular Atrophy (SMA) Treatment Market Size, Status and Forecast 2021-2027
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Spinal Muscular Atrophy (SMA) Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Type I Spinal Muscular Atrophy (SMA)
1.2.3 Type II Spinal Muscular Atrophy (SMA)
1.2.4 Type III Spinal Muscular Atrophy (SMA)
1.3 Market by Application
1.3.1 Global Spinal Muscular Atrophy (SMA) Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Diagnostic Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Spinal Muscular Atrophy (SMA) Treatment Market Perspective (2016-2027)
2.2 Spinal Muscular Atrophy (SMA) Treatment Growth Trends by Regions
2.2.1 Spinal Muscular Atrophy (SMA) Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Spinal Muscular Atrophy (SMA) Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Spinal Muscular Atrophy (SMA) Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Spinal Muscular Atrophy (SMA) Treatment Industry Dynamic
2.3.1 Spinal Muscular Atrophy (SMA) Treatment Market Trends
2.3.2 Spinal Muscular Atrophy (SMA) Treatment Market Drivers
2.3.3 Spinal Muscular Atrophy (SMA) Treatment Market Challenges
2.3.4 Spinal Muscular Atrophy (SMA) Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Spinal Muscular Atrophy (SMA) Treatment Players by Revenue
3.1.1 Global Top Spinal Muscular Atrophy (SMA) Treatment Players by Revenue (2016-2021)
3.1.2 Global Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Spinal Muscular Atrophy (SMA) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Spinal Muscular Atrophy (SMA) Treatment Revenue
3.4 Global Spinal Muscular Atrophy (SMA) Treatment Market Concentration Ratio
3.4.1 Global Spinal Muscular Atrophy (SMA) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Spinal Muscular Atrophy (SMA) Treatment Revenue in 2020
3.5 Spinal Muscular Atrophy (SMA) Treatment Key Players Head office and Area Served
3.6 Key Players Spinal Muscular Atrophy (SMA) Treatment Product Solution and Service
3.7 Date of Enter into Spinal Muscular Atrophy (SMA) Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Spinal Muscular Atrophy (SMA) Treatment Breakdown Data by Type
4.1 Global Spinal Muscular Atrophy (SMA) Treatment Historic Market Size by Type (2016-2021)
4.2 Global Spinal Muscular Atrophy (SMA) Treatment Forecasted Market Size by Type (2022-2027)
5 Spinal Muscular Atrophy (SMA) Treatment Breakdown Data by Application
5.1 Global Spinal Muscular Atrophy (SMA) Treatment Historic Market Size by Application (2016-2021)
5.2 Global Spinal Muscular Atrophy (SMA) Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Spinal Muscular Atrophy (SMA) Treatment Market Size (2016-2027)
6.2 North America Spinal Muscular Atrophy (SMA) Treatment Market Size by Type
6.2.1 North America Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2016-2021)
6.2.2 North America Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2022-2027)
6.2.3 North America Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2016-2027)
6.3 North America Spinal Muscular Atrophy (SMA) Treatment Market Size by Application
6.3.1 North America Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2016-2021)
6.3.2 North America Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2022-2027)
6.3.3 North America Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2016-2027)
6.4 North America Spinal Muscular Atrophy (SMA) Treatment Market Size by Country
6.4.1 North America Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2016-2021)
6.4.2 North America Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Spinal Muscular Atrophy (SMA) Treatment Market Size (2016-2027)
7.2 Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Type
7.2.1 Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2016-2021)
7.2.2 Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2022-2027)
7.2.3 Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2016-2027)
7.3 Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Application
7.3.1 Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2016-2021)
7.3.2 Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2022-2027)
7.3.3 Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2016-2027)
7.4 Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Country
7.4.1 Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2016-2021)
7.4.2 Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size (2016-2027)
8.2 Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size by Type
8.2.1 Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size by Application
8.3.1 Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size by Region
8.4.1 Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size (2016-2027)
9.2 Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size by Type
9.2.1 Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2016-2027)
9.3 Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size by Application
9.3.1 Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2016-2027)
9.4 Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size by Country
9.4.1 Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size (2016-2027)
10.2 Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Type
10.2.1 Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Application
10.3.1 Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Country
10.4.1 Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Spinal Muscular Atrophy (SMA) Treatment Introduction
11.1.4 Pfizer Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Isis Pharmaceuticals
11.2.1 Isis Pharmaceuticals Company Details
11.2.2 Isis Pharmaceuticals Business Overview
11.2.3 Isis Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Introduction
11.2.4 Isis Pharmaceuticals Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2016-2021)
11.2.5 Isis Pharmaceuticals Recent Development
11.3 Biogen Idec
11.3.1 Biogen Idec Company Details
11.3.2 Biogen Idec Business Overview
11.3.3 Biogen Idec Spinal Muscular Atrophy (SMA) Treatment Introduction
11.3.4 Biogen Idec Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2016-2021)
11.3.5 Biogen Idec Recent Development
11.4 Boehringer Ingelheim
11.4.1 Boehringer Ingelheim Company Details
11.4.2 Boehringer Ingelheim Business Overview
11.4.3 Boehringer Ingelheim Spinal Muscular Atrophy (SMA) Treatment Introduction
11.4.4 Boehringer Ingelheim Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2016-2021)
11.4.5 Boehringer Ingelheim Recent Development
11.5 F. Hoffmann-La Roche
11.5.1 F. Hoffmann-La Roche Company Details
11.5.2 F. Hoffmann-La Roche Business Overview
11.5.3 F. Hoffmann-La Roche Spinal Muscular Atrophy (SMA) Treatment Introduction
11.5.4 F. Hoffmann-La Roche Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2016-2021)
11.5.5 F. Hoffmann-La Roche Recent Development
11.6 Regeneron Pharmaceuticals
11.6.1 Regeneron Pharmaceuticals Company Details
11.6.2 Regeneron Pharmaceuticals Business Overview
11.6.3 Regeneron Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Introduction
11.6.4 Regeneron Pharmaceuticals Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2016-2021)
11.6.5 Regeneron Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Figures, Tables and Charts Available in Global Spinal Muscular Atrophy (SMA) Treatment Market Size, Status and Forecast 2021-2027
List of TablesTable 1. Global Spinal Muscular Atrophy (SMA) Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Type I Spinal Muscular Atrophy (SMA)
Table 3. Key Players of Type II Spinal Muscular Atrophy (SMA)
Table 4. Key Players of Type III Spinal Muscular Atrophy (SMA)
Table 5. Global Spinal Muscular Atrophy (SMA) Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Spinal Muscular Atrophy (SMA) Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Spinal Muscular Atrophy (SMA) Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Spinal Muscular Atrophy (SMA) Treatment Market Share by Regions (2016-2021)
Table 9. Global Spinal Muscular Atrophy (SMA) Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Spinal Muscular Atrophy (SMA) Treatment Market Share by Regions (2022-2027)
Table 11. Spinal Muscular Atrophy (SMA) Treatment Market Trends
Table 12. Spinal Muscular Atrophy (SMA) Treatment Market Drivers
Table 13. Spinal Muscular Atrophy (SMA) Treatment Market Challenges
Table 14. Spinal Muscular Atrophy (SMA) Treatment Market Restraints
Table 15. Global Spinal Muscular Atrophy (SMA) Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Spinal Muscular Atrophy (SMA) Treatment Market Share by Players (2016-2021)
Table 17. Global Top Spinal Muscular Atrophy (SMA) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Spinal Muscular Atrophy (SMA) Treatment as of 2020)
Table 18. Ranking of Global Top Spinal Muscular Atrophy (SMA) Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Spinal Muscular Atrophy (SMA) Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Spinal Muscular Atrophy (SMA) Treatment Product Solution and Service
Table 22. Date of Enter into Spinal Muscular Atrophy (SMA) Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Spinal Muscular Atrophy (SMA) Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Spinal Muscular Atrophy (SMA) Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Spinal Muscular Atrophy (SMA) Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. Pfizer Company Details
Table 63. Pfizer Business Overview
Table 64. Pfizer Spinal Muscular Atrophy (SMA) Treatment Product
Table 65. Pfizer Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2016-2021) & (US$ Million)
Table 66. Pfizer Recent Development
Table 67. Isis Pharmaceuticals Company Details
Table 68. Isis Pharmaceuticals Business Overview
Table 69. Isis Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Product
Table 70. Isis Pharmaceuticals Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2016-2021) & (US$ Million)
Table 71. Isis Pharmaceuticals Recent Development
Table 72. Biogen Idec Company Details
Table 73. Biogen Idec Business Overview
Table 74. Biogen Idec Spinal Muscular Atrophy (SMA) Treatment Product
Table 75. Biogen Idec Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2016-2021) & (US$ Million)
Table 76. Biogen Idec Recent Development
Table 77. Boehringer Ingelheim Company Details
Table 78. Boehringer Ingelheim Business Overview
Table 79. Boehringer Ingelheim Spinal Muscular Atrophy (SMA) Treatment Product
Table 80. Boehringer Ingelheim Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2016-2021) & (US$ Million)
Table 81. Boehringer Ingelheim Recent Development
Table 82. F. Hoffmann-La Roche Company Details
Table 83. F. Hoffmann-La Roche Business Overview
Table 84. F. Hoffmann-La Roche Spinal Muscular Atrophy (SMA) Treatment Product
Table 85. F. Hoffmann-La Roche Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2016-2021) & (US$ Million)
Table 86. F. Hoffmann-La Roche Recent Development
Table 87. Regeneron Pharmaceuticals Company Details
Table 88. Regeneron Pharmaceuticals Business Overview
Table 89. Regeneron Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Product
Table 90. Regeneron Pharmaceuticals Revenue in Spinal Muscular Atrophy (SMA) Treatment Business (2016-2021) & (US$ Million)
Table 91. Regeneron Pharmaceuticals Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Spinal Muscular Atrophy (SMA) Treatment Market Share by Type: 2020 VS 2027
Figure 2. Type I Spinal Muscular Atrophy (SMA) Features
Figure 3. Type II Spinal Muscular Atrophy (SMA) Features
Figure 4. Type III Spinal Muscular Atrophy (SMA) Features
Figure 5. Global Spinal Muscular Atrophy (SMA) Treatment Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Ambulatory Surgical Centers Case Studies
Figure 8. Diagnostic Centers Case Studies
Figure 9. Others Case Studies
Figure 10. Spinal Muscular Atrophy (SMA) Treatment Report Years Considered
Figure 11. Global Spinal Muscular Atrophy (SMA) Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Spinal Muscular Atrophy (SMA) Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Spinal Muscular Atrophy (SMA) Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Spinal Muscular Atrophy (SMA) Treatment Market Share by Regions (2022-2027)
Figure 15. Global Spinal Muscular Atrophy (SMA) Treatment Market Share by Players in 2020
Figure 16. Global Top Spinal Muscular Atrophy (SMA) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Spinal Muscular Atrophy (SMA) Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Spinal Muscular Atrophy (SMA) Treatment Revenue in 2020
Figure 18. Global Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Spinal Muscular Atrophy (SMA) Treatment Market Share by Type (2016-2027)
Figure 22. North America Spinal Muscular Atrophy (SMA) Treatment Market Share by Application (2016-2027)
Figure 23. North America Spinal Muscular Atrophy (SMA) Treatment Market Share by Country (2016-2027)
Figure 24. United States Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Spinal Muscular Atrophy (SMA) Treatment Market Share by Type (2016-2027)
Figure 28. Europe Spinal Muscular Atrophy (SMA) Treatment Market Share by Application (2016-2027)
Figure 29. Europe Spinal Muscular Atrophy (SMA) Treatment Market Share by Country (2016-2027)
Figure 30. Germany Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Share by Region (2016-2027)
Figure 40. China Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Spinal Muscular Atrophy (SMA) Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Spinal Muscular Atrophy (SMA) Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Spinal Muscular Atrophy (SMA) Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Spinal Muscular Atrophy (SMA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Pfizer Revenue Growth Rate in Spinal Muscular Atrophy (SMA) Treatment Business (2016-2021)
Figure 60. Isis Pharmaceuticals Revenue Growth Rate in Spinal Muscular Atrophy (SMA) Treatment Business (2016-2021)
Figure 61. Biogen Idec Revenue Growth Rate in Spinal Muscular Atrophy (SMA) Treatment Business (2016-2021)
Figure 62. Boehringer Ingelheim Revenue Growth Rate in Spinal Muscular Atrophy (SMA) Treatment Business (2016-2021)
Figure 63. F. Hoffmann-La Roche Revenue Growth Rate in Spinal Muscular Atrophy (SMA) Treatment Business (2016-2021)
Figure 64. Regeneron Pharmaceuticals Revenue Growth Rate in Spinal Muscular Atrophy (SMA) Treatment Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Keyplayers in Global Spinal Muscular Atrophy (SMA) Treatment Market Size, Status and Forecast 2021-2027
PfizerIsis Pharmaceuticals
Biogen Idec
Boehringer Ingelheim
F. Hoffmann-La Roche
Regeneron Pharmaceuticals
